- Products
- News
- Resources
- Company
- Marketplace Login
- Book A Demo
FUNDRAISING NEWS | January 30, 2025
Tags: Venture Capital, Fundraising
Curie.Bio said it raised $342.1M for its sophomore seed fund, Curie Bio Seed Fund II.
The fund, which made its first sale on January 17, secured commitments from 46 investors, according to a January 29 filing with the SEC. The fund's predecessor, Curie Bio Seed Fund I, targeted a $275M fundraise.
In June 2024, the biotechnology-focused venture capital firm announced the $380M close of its series A fund, bringing its total fundraising at the time to nearly $1B. The fund was used to support clinical trials of early-stage therapeutic companies.
Curie.Bio targets platform and asset-centric companies with programs that have blockbuster potential. So far, it has raised nearly $1B and built a portfolio of 20 early-stage therapeutics companies from different business areas and geographies.
Written By: Dakota
Junction Growth Investors Raises €115M for Maiden Fund
February 11, 2025
Reuters Launches $150M Second Corporate Venture Capital Fund
February 10, 2025
VC Firm Kindred Ventures Seeks $200M for Fourth Fund
February 07, 2025
Hitachi Targets $400M for Fourth Corporate VC Fund
February 07, 2025
Hamilton Lane's First Venture Access Fund Closes at $615.3M
February 07, 2025
925 West Lancaster Ave
Suite 220
Bryn Mawr, PA 19010
Tel: (610) 642-1481
© Dakota 2025 | Terms of Use | Privacy Policy
